Trial intelligence / Profile preview

Nebulized l-epinephrine dose comparison for post-extubation stridor

ACTRN12610000759099Phase 3Completed

Sponsor
Paulo Sergio Lucas da Silva
Start
Oct 2010
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of epinephrine in post-extubation stridor (PES) and upper airway obstruction (UAO) (3 arms), sponsored by Paulo Sergio Lucas da Silva. Primary endpoint: Mean change in post-extubation stridor score. Started Oct 2010; status: completed.

02

Drugs

epinephrine
03

Conditions

post-extubation stridor (PES)upper airway obstruction (UAO)

Beyond the preview

Go deeper on ACTRN12610000759099.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12610000759099.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call